Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.6105
+0.0103 (1.72%)
At close: May 6, 2026, 4:00 PM EDT
0.6105
0.00 (0.00%)
After-hours: May 6, 2026, 4:25 PM EDT
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $24.19 million as of May 6, 2026. Its market cap has decreased by -60.09% in one year.
Market Cap
24.19M
Enterprise Value
-36.45M
1-Year Change
-60.09%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $24.19M, an increase of 160.09%. That is a compound annual growth rate of 10.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 23.80M | -8.81% |
| Dec 31, 2025 | 26.10M | -68.21% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
| May 11, 2016 | 9.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 27.60M |
| Outlook Therapeutics | 27.46M |
| Dyadic International | 27.37M |
| Marker Therapeutics | 26.01M |
| ABVC BioPharma | 25.95M |
| Barinthus Biotherapeutics | 25.94M |
| Longeveron | 25.26M |
| Lantern Pharma | 25.00M |